Lincoln Pharmaceuticals Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
101,846.20
198,457.30
330,655.30
368,430.20
-
Depreciation, Depletion & Amortization
35,490.20
45,681.10
48,658.10
55,364.40
-
Other Funds
33,576.50
36,247.40
81,873.50
69,210.60
-
Funds from Operations
163,172.10
207,891.00
297,439.80
354,584.10
407,347.00
Changes in Working Capital
175,594.20
18,047.90
48,044.00
178,199.00
-
Net Operating Cash Flow
12,422.00
189,843.00
345,483.80
176,385.00
-
Capital Expenditures
39,164.70
39,354.90
337,297.00
176,020.10
-
Sale of Fixed Assets & Businesses
726.20
1,012.00
1,726.00
170.00
-
Purchase/Sale of Investments
42,435.70
116,920.90
12,099.00
93,840.20
-
Net Investing Cash Flow
3,997.20
64,328.50
421,072.70
269,690.30
-
Cash Dividends Paid - Total
11,449.70
11,449.70
19,723.80
19,571.10
-
Issuance/Reduction of Debt, Net
24,341.80
252,323.50
15,615.50
118,127.00
-
Net Financing Cash Flow
35,791.50
263,773.20
71,520.30
89,187.70
-
Net Change in Cash
44,216.30
9,601.60
4,068.60
4,117.60
-
Free Cash Flow
51,586.70
150,488.10
8,186.80
364.90
-
Deferred Taxes & Investment Tax Credit
7,740.70
-
-
-
-
Net Assets from Acquisitions
-
14,249.40
73,402.80
-
-
Change in Capital Stock
-
-
75,628.60
226,885.80
-
About Lincoln Pharmaceuticals
View Profile
